Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities |
| |
| Affiliation: | 1. Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK;2. Centre for Research on Drugs & Health Behaviour, London School of Hygiene & Tropical Medicine, London, UK;3. School of Social and Community Medicine, University of Bristol, Bristol, UK;4. Microbiology Services, Public Health England, London, UK;1. Department of Criminology and Criminal Justice, University of South Carolina, 1305 Greene Street, Columbia, SC 29208, USA;2. RAND Drug Policy Research Center, RAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA 90407-2138, USA;1. University of California, San Francisco, United States;2. University of Pennsylvania, United States;3. Harvard Medical School, United States;4. Columbia University, United States;1. Faculty of Human Movement Sciences, VU University Amsterdam, Van der Boechorststraat 9, 1081 BT Amsterdam, The Netherlands;2. Anti-Doping Authority of the Netherlands, Cypresbaan 21, 2908 LT Capelle aan den IJssel, The Netherlands;1. Departamento de Ingeniería Industrial, Universidad de Antioquia, Colombia, Calle 67 # 53-108, Office 21-407, Medellin, Colombia;2. Universidad Jorge Tadeo Lozano and Universidad Nacional de Colombia, AA 1027 Medellin, Colombia |
| |
| Abstract: | BackgroundPeople who inject drugs (PWID) are at risk of injection site infections and injuries. The factors associated with recent symptoms of these problems are examined.MethodPWID recruited using respondent driven sampling, underwent a computer-assisted interview and provided a dried-blood spot sample. Weight data were examined using logistic regression.ResultsThe mean age of the 855 participants was 32 years, and 25% were women. During the preceding 28 days, 94% had injected heroin and 50% crack-cocaine; with 41% injecting into their arms and 47% their groin. The passing on of used needles/syringes was reported by 9.7% and receiving by 8.0%. During the preceding 28 days, 21% reported having redness, swelling and tenderness, 6.1% an abscess, and 5.2% a sore/open wound at an injection site; with a quarter (24%) reporting one or more of these. A range of factors were associated with these symptoms; all three symptoms were associated with more frequent injection and the use of multiple injection sites; two of the symptoms were also associated with having recently overdosed and the use of particular injection sites.ConclusionsInjection site infections and injuries are common among PWID and targeted interventions are needed to reduce risk. |
| |
| Keywords: | People who inject drugs Injection site infections and injuries England |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
